RHEUMATOID ARTHRITIS (RA)

This study monitored the safety and real-world effectiveness of the drug upadacitinib in Korean patients. It included over 2,300 people with conditions like rheumatoid arthritis, atopic dermatitis, ankylosing spondylitis, or psoriatic arthritis. Participants took the drug as pres…

This study tested whether Acthar gel injections could help control sudden worsening of rheumatoid arthritis symptoms, known as flares. Forty adults with active flares received either a lower or higher dose of Acthar for four weeks. Researchers used joint ultrasounds and standard …

This study followed 413 Canadian adults with moderate to severe rheumatoid arthritis who were prescribed upadacitinib by their doctors. Researchers tracked patients for two years to see how well the medication controlled their joint pain, stiffness, and swelling in real-world set…

This study looked at how bone density changes over time in postmenopausal women with rheumatoid arthritis, a condition that increases fracture risk. Researchers followed 82 women to see how different combinations of arthritis medications and bone-strengthening treatments affected…

This early-stage study tested the safety of a new oral medication called ARD-885 in healthy volunteers and people with rheumatoid arthritis. Researchers examined how different doses were tolerated and how the drug moved through the body, including whether food affected its absorp…

This pilot study tested whether a new care model called PREVAIL could be successfully integrated into routine rheumatology visits for adults with rheumatoid arthritis (RA). The model used a screening tool to identify patients who might benefit from exercise guidance or a physical…

This study tested whether a traditional therapy involving burial in hot desert sand could help people with rheumatoid arthritis breathe better, move more easily, and feel less pain. Researchers compared this five-day sand therapy to a two-month program of standard physical therap…

This study observed the safety and effectiveness of the approved rheumatoid arthritis drug RINVOQ in real-world medical practice. Researchers reviewed the medical records of over 4,000 Japanese patients taking the drug for up to three years. The main goal was to track the occurre…

This study aimed to monitor the long-term safety of the arthritis drug abatacept after it was approved for use. It tracked over 38,000 people in Denmark with rheumatoid or psoriatic arthritis who were taking the drug. The main goal was to see how often certain cancers, especially…

This study compared how much patients with rheumatoid arthritis and knee osteoarthritis know about heart disease risks. Researchers surveyed 120 patients about their knowledge, exercise habits, and nutrition attitudes. The goal was to identify gaps in awareness and help guide pat…